check_circleStudy Completed
Primary pulmonary hypertension
Bayer Identifier:
15762
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
EU CT Number:
Not Available
Ventavis 20:PK compared with Ventavis 10 in healthy subjects
Trial purpose
Please see attached Study Results Summary below.
Key Participants Requirements
Sex
N/AAge
N/ATrial summary
Enrollment Goal
21Trial Dates
May 2012 - June 2012Phase
Phase 1Could I Receive a placebo
N/AProducts
Ventavis (Iloprost, BAYQ6256)Accepts Healthy Volunteer
N/AWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Bayer Pharma AG | Berlin, 13353, Germany |
Trial design
Trial Type
InterventionalIntervention Type
N/ATrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A